MedPath

Sunbit UV Measuring Device to Track Sun Behavior

Terminated
Conditions
Immunosuppression
Skin Neoplasms
Registration Number
NCT02221843
Lead Sponsor
University of Zurich
Brief Summary

Sunbit is a new wearable UV dosimeter to measure solar radiation in real time. The purpose of this study is to track sun behavior of patients at high risk for skin cancer, to investigate the feasibility of this prototype in daily life and to investigate the technical accuracy of the Sunbit.

Detailed Description

A total of 20 patients will be included to wear the Sunbit system during the time of 4 weeks. After this 4 weeks Sunbit will be recollected and data in the form of UV Indices will be extracted and analyzed.

Patients will be recruited in the Department of Dermatology of the University Hospital Zürich. The target population comprises patients with a high risk of melanoma and non-melanoma skin cancer, thus especially patients with an immunosuppressive therapy due to organ transplantation.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Age ≥ 18 years
  • History of skin cancer (melanoma or NMSC) or patients with high risk of skin cancer (e.g. immunosuppressive therapy)
  • Oral and written informed consent
Read More
Exclusion Criteria
  • Any medical condition that renders the patient bedridden for the duration of 2 weeks
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
number of days wearing the deviceafter 4 weeks wearing the device

patient compliance

Secondary Outcome Measures
NameTimeMethod
difference between measured UV Indices and reference valuesafter 4 weeks wearing the device

technical accuracy of the device

Trial Locations

Locations (1)

Department of Dermatology of the University Hospital Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath